3 Reasons to Sell ASGN and 1 Stock to Buy Instead
What a brutal six months it’s been for ASGN. The stock has dropped 27.3% and now trades at $67.80, rattling many shareholders. This was partly driven by its softer quarterly results and might have i
Reflecting On Traditional Fast Food Stocks’ Q4 Earnings: Krispy Kreme (NASDAQ:DNUT)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Krispy Kreme (NASDAQ:DNUT) and the best a
Spotting Winners: e.l.f. Beauty (NYSE:ELF) And Personal Care Stocks In Q4
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the personal care industry, including e.l.f. Beauty (NYSE:ELF) and its peers.
Q4 Earnings Highlights: Rapid7 (NASDAQ:RPD) Vs The Rest Of The Cybersecurity Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Rapid7 (NASDAQ:RPD) and the best and wors
Consumer Subscription Stocks Q4 Earnings: Udemy (NASDAQ:UDMY) Best of the Bunch
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Udemy (NASDAQ:UDMY) and the
Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the immuno-oncology stocks, including Natera (NASDAQ:NTRA) and its peers.
Electronic Components Stocks Q4 Results: Benchmarking Belden (NYSE:BDC)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the electronic components stocks, including Belden (NYSE:BDC) and its peers.
3 Reasons to Sell SMPL and 1 Stock to Buy Instead
Simply Good Foods has been treading water for the past six months, recording a small loss of 2.3% while holding steady at $33.11.
3 Reasons ALLE is Risky and 1 Stock to Buy Instead
Over the last six months, Allegion’s shares have sunk to $128.65, producing a disappointing 8.4% loss while the S&P 500 was flat. This might have investors contemplating their next move.
3 Reasons ARCB is Risky and 1 Stock to Buy Instead
What a brutal six months it’s been for ArcBest. The stock has dropped 34.7% and now trades at $71.76, rattling many shareholders. This might have investors contemplating their next move.